Halbert Hargrove Global Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.1K Buy
34
+2
+6% +$960 ﹤0.01% 275
2026
Q1
$15.7K Hold
32
﹤0.01% 263
2025
Q4
$18.5K Sell
32
-18
-36% -$10.2K ﹤0.01% 255
2025
Q3
$24.3K Buy
50
+1
+2% +$465 ﹤0.01% 237
2025
Q2
$19.9K Buy
49
+4
+9% +$1.67K ﹤0.01% 190
2025
Q1
$22.4K Hold
45
﹤0.01% 191
2024
Q4
$23.4K Buy
+45
New +$24.7K ﹤0.01% 186
2023
Q2
Sell
-1,258
Closed -$725K 161
2023
Q1
$725K Buy
1,258
+54
+4% +$30.4K 0.05% 61
2022
Q4
$663K Sell
1,204
-85
-7% -$45K 0.05% 65
2022
Q3
$654K Buy
1,289
+7
+0.5% +$3.92K 0.05% 66
2022
Q2
$697K Sell
1,282
-16
-1% -$8.81K 0.05% 65
2022
Q1
$766K Buy
1,298
+109
+9% +$62.6K 0.05% 65
2021
Q4
$793K Sell
1,189
-114
-9% -$71.2K 0.05% 63
2021
Q3
$745K Sell
1,303
-75
-5% -$41.2K 0.05% 52
2021
Q2
$695K Buy
1,378
+79
+6% +$37.3K 0.05% 62
2021
Q1
$593K Sell
1,299
-14
-1% -$6.68K 0.04% 61
2020
Q4
$612K Buy
1,313
+150
+13% +$70.3K 0.05% 53
2020
Q3
$514K Buy
1,163
+4
+0.3% +$1.65K 0.05% 48
2020
Q2
$420K Sell
1,159
-85
-7% -$28.5K 0.06% 46
2020
Q1
$353K Sell
1,244
-115
-8% -$36.3K 0.06% 45
2019
Q4
$441K Sell
1,359
-52
-4% -$15.8K 0.11% 42
2019
Q3
$411K Sell
1,411
-10
-0.7% -$2.86K 0.11% 46
2019
Q2
$417K Buy
+1,421
New +$391K 0.11% 40
2019
Q1
Sell
-1,564
Closed -$350K 77
2018
Q4
$350K Sell
1,564
-104
-6% -$24.4K 0.08% 46
2018
Q3
$407K Sell
1,668
-25
-1% -$5.75K 0.11% 35
2018
Q2
$351K Sell
1,693
-3
-0.2% -$637 0.09% 43
2018
Q1
$350K Buy
1,696
+267
+19% +$56K 0.09% 39
2017
Q4
$271K Buy
1,429
+5
+0.4% +$958 0.07% 54
2017
Q3
$269K Sell
1,424
-455
-24% -$82.4K 0.07% 51
2017
Q2
$328K Sell
1,879
-269
-13% -$45.2K 0.09% 46
2017
Q1
$330K Sell
2,148
-12
-0.6% -$1.83K 0.08% 50
2016
Q4
$305K Sell
2,160
-13
-0.6% -$1.92K 0.08% 47
2016
Q3
$346K Sell
2,173
-84
-4% -$12.9K 0.1% 41
2016
Q2
$334K Sell
2,257
-152
-6% -$22.4K 0.1% 45
2016
Q1
$341K Sell
2,409
-398
-14% -$53.3K 0.12% 43
2015
Q4
$398K Sell
2,807
-12
-0.4% -$1.6K 0.17% 41
2015
Q3
$345K Sell
2,819
-2,979
-51% -$388K 0.17% 48
2015
Q2
$752K Sell
5,798
-204
-3% -$26.6K 0.18% 41
2015
Q1
$806K Buy
6,002
+2,654
+79% +$342K 0.26% 40
2014
Q4
$419K Sell
3,348
-80
-2% -$9.73K 0.21% 51
2014
Q3
$417K Sell
3,428
-376
-10% -$45.7K 0.12% 68
2014
Q2
$449K Sell
3,804
-189
-5% -$22.2K 0.14% 53
2014
Q1
$480K Sell
3,993
-615
-13% -$73.1K 0.15% 44
2013
Q4
$513K Sell
4,608
-649
-12% -$64.5K 0.16% 41
2013
Q3
$484K Sell
5,257
-57
-1% -$5.16K 0.16% 43
2013
Q2
$450K Buy
+5,314
New +$442K 0.16% 51

Other funds holding TMO

Halbert Hargrove Global Advisors's TMO Position: Q2 2026 in Review

Halbert Hargrove Global Advisors increased its Thermo Fisher Scientific (TMO) stake by 6.3% in Q2 2026, buying an estimated $960 and bringing the position to 34 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #275.

Halbert Hargrove Global Advisors first reported a position in TMO in Q2 2013 and has held it in 46 quarters since. The position peaked at $806K in Q1 2015. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Halbert Hargrove Global Advisors held 34 shares of Thermo Fisher Scientific worth $17.1K as of Q2 2026.
  • Halbert Hargrove Global Advisors bought 2 Thermo Fisher Scientific shares in Q2 2026, an estimated $960.
  • Thermo Fisher Scientific made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #275 holding.
  • Halbert Hargrove Global Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 46 quarters since.
  • Halbert Hargrove Global Advisors's Thermo Fisher Scientific position peaked at $806K in Q1 2015.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.